A Clinical Focus on Non-Alcoholic Fatty Liver Disease

A Clinical Focus on Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Australia. It is closely associated with obesity and is a serious health condition. It can progress to nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis and hepatocellular carcinoma, and is a common reason for liver transplant. Consequences of NAFLD extend beyond the liver with increased risk of cardiovascular disease, hypertension, diabetes, gall stones, kidney stones and chronic renal impairment.

In this presentation, Berris will explore the clinical implications of NAFLD and will discuss the lifestyle modifications and key herbs for the treatment and management of NAFLD patients. This information will be based on research and her clinical experience.

 

Webinar Details

Date: Saturday 4th December 2021
Time: 1pm ADST | 12pm AEST | 12:30pm ADCT | 10am AWST
CPE Points: 1
Where: Online
Cost: FREE